Perron Institute

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• ALS (motor neurone disease)1 trial
• Dermatomyositis and polymyositis (myositis)1 trial
• Huntington's disease1 trial
• Multiple sclerosis1 trial

Phase

• Phase 22 trials
• Phase 1/21 trial
• Phase 31 trial

Status

• Not yet recruiting2 trials
• Recruiting2 trials

Lead sponsor

• Boehringer Ingelheim1 trial
• Celgene1 trial
• Nura Bio1 trial
• Western Sydney Local Health District1 trial

Running trials

• Not yet recruiting

  A Study to Understand How Nerandomilast Works in People With Active Idiopathic Inflammatory Myopathies

  NCT07789015· Phase 3· Boehringer Ingelheim· Source

  Contact: Boehringer Ingelheim

• Recruiting

  A Clinical Trial to Evaluate NB-4746 in Participants With Amyotrophic Lateral Sclerosis.

  NCT07369076· Phase 1/2· Nura Bio· Source

  Contact: Ruby Shehatha

• Recruiting

  A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity

  NCT06782490· Phase 2· Celgene· Source

  Contact: william Carroll, Site 0019

• Recruiting

  A Randomised Controlled Trial, Of N-Acetyl Cysteine (NAC), for Premanifest Huntingtin Gene Expansion Carriers

  NCT05509153· Phase 2· Western Sydney Local Health District· Source

  Contact: Carolyn Orr

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• ALS (motor neurone disease)1 recruiting
• Dermatomyositis and polymyositis (myositis)1 recruiting
• Huntington's disease1 recruiting
• Multiple sclerosis1 recruiting